CHRISTOPHER BRUNE: Open Payments
NPI 1679930648 · WATKINSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$893 in 44 payments from 12 companies in 2025. Trend: 2023 $1,482 · 2024 $1,499 · 2025 $893
Food & beverage: $893
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $176 |
| ABBVIE INC. | 12 | $175 |
| Galderma Laboratories, L.P. | 7 | $119 |
| UCB, Inc. | 3 | $114 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
| Incyte Corporation | 3 | $66 |
| Organon LLC | 4 | $55 |
| LEO Pharma Inc. | 2 | $47 |
| Amgen Inc. | 1 | $23 |
| PFIZER INC. | 1 | $18 |
Products named: DUPIXENT, SKYRIZI, NEMLUVIO, Bimzelx, OPZELURA, RINVOQ, Rhapsido, ADBRY.
Industry payments across GA — which companies pay providers there.
